James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 46,781 shares at $55.15 ($2.6M) on 2020-07-09, disclosed to the SEC on 2020-07-13.
Open-market sale of $2.6M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.65 | 12,361 | $676K | 26.3% |
| 2 | $54.65 | 12,361 | $676K | 26.3% |
| 3 | $55.15 | 9,050 | $499K | 19.4% |
| 4 | $55.15 | 9,050 | $499K | 19.4% |
| 5 | $56.24 | 1,829 | $103K | 4.0% |
| 6 | $56.24 | 1,829 |
| $103K |
| 4.0% |
| 7 | $57.02 | 301 | $17K | 0.7% |
| Total | $54.98 avg | 46,781 | $2.6M | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |